Literature DB >> 15730394

Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.

S Andersson1, O Larsen, Z Da Silva, H Linder, H Norrgren, F Dias, R Thorstensson, P Aaby, G Biberfeld.   

Abstract

Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses were determined in cultures of peripheral blood mononuclear cells from HIV-2-exposed uninfected individuals, HIV-2-infected individuals and HIV-negative controls in Guinea-Bissau. Increased HIV-2-specific T lymphocyte proliferative responses were detected in both groups compared to HIV-negative controls (healthy HIV-uninfected individuals without known exposure to an HIV-infected person); five out of 29 of the HIV-2-exposed uninfected and half (16 of 32) of the HIV-2-infected individuals had stimulation indexes >2, compared to one out of 49 of the HIV-negative controls (P = 0.003 and P < 0.0001, respectively). The exposed uninfected individuals had reactivity to a HIV-2 V3-peptide corresponding to amino acids 311-326 of the envelope glycoprotein, while the HIV-2-infected people reacted mainly to HIV-2 whole viral lysate. Thus, this study demonstrates a high degree of HIV-2-specific T helper cell activity, as measured by lymphocyte proliferation, in HIV-2-exposed uninfected individuals as well as in HIV-2-infected subjects. These immune responses could be important for resistance to the infection and for the control of established infection and, thus, play a role in the lower transmission and progression of HIV-2 compared to HIV-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730394      PMCID: PMC1809326          DOI: 10.1111/j.1365-2249.2005.02723.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  62 in total

1.  New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; K Fowke; T Dong; P Kiama; J Rutherford; E Njagi; F Mwangi; T Rostron; J Onyango; J Oyugi; K S MacDonald; J J Bwayo; F A Plummer
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

2.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge.

Authors:  B Mäkitalo; P Böttiger1; G Biberfeld; R Thorstensson
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

4.  Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.

Authors:  D O'Donovan; K Ariyoshi; P Milligan; M Ota; L Yamuah; R Sarge-Njie; H Whittle
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

5.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

Authors:  R Kaul; T Dong; F A Plummer; J Kimani; T Rostron; P Kiama; E Njagi; E Irungu; B Farah; J Oyugi; R Chakraborty; K S MacDonald; J J Bwayo; A McMichael; S L Rowland-Jones
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

6.  A divergent simian immunodeficiency virus from sooty mangabey with an atypical Tat-TAR structure.

Authors:  L A Chakrabarti; A Luckay; P A Marx
Journal:  AIDS Res Hum Retroviruses       Date:  2001-08-10       Impact factor: 2.205

7.  Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.

Authors:  Geoffrey S Gottlieb; Papa Salif Sow; Stephen E Hawes; Ibra Ndoye; Mary Redman; Awa M Coll-Seck; Mame A Faye-Niang; Aissatou Diop; Jane M Kuypers; Cathy W Critchlow; Richard Respess; James I Mullins; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

8.  Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections.

Authors:  V Shanmugam; W M Switzer; J N Nkengasong; G García-Lerma; T A Green; E Ekpini; M Sassan-Morokro; F Antunes; K Manshino; V Soriano; S Z Wiktor; W Heneine
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

9.  Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.

Authors:  S Andersson; H Norrgren; Z da Silva; A Biague; S Bamba; S Kwok; C Christopherson; G Biberfeld; J Albert
Journal:  Arch Intern Med       Date:  2000-11-27

10.  HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production.

Authors:  K R Fowke; T Dong; S L Rowland-Jones; J Oyugi; W J Rutherford; J Kimani; P Krausa; J Bwayo; J N Simonsen; G M Shearer; F A Plummer
Journal:  AIDS Res Hum Retroviruses       Date:  1998-11-20       Impact factor: 2.205

View more
  1 in total

Review 1.  HIV-2 as a model to identify a functional HIV cure.

Authors:  Joakim Esbjörnsson; Marianne Jansson; Sanne Jespersen; Fredrik Månsson; Bo L Hønge; Jacob Lindman; Candida Medina; Zacarias J da Silva; Hans Norrgren; Patrik Medstrand; Sarah L Rowland-Jones; Christian Wejse
Journal:  AIDS Res Ther       Date:  2019-09-05       Impact factor: 2.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.